ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him

August 4, 1978

IOM Calls For Rapid Reform Of Health Case System.

March 9, 2001

Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures

March 4, 1994